Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $359.31 million. The enterprise value is $105.72 million.
| Market Cap | 359.31M |
| Enterprise Value | 105.72M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 345.49 million shares outstanding. The number of shares has increased by 31.69% in one year.
| Current Share Class | 345.49M |
| Shares Outstanding | 345.49M |
| Shares Change (YoY) | +31.69% |
| Shares Change (QoQ) | +5.22% |
| Owned by Insiders (%) | 5.54% |
| Owned by Institutions (%) | 73.17% |
| Float | 281.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 77.44 |
| Forward PS | 23,607.79 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.72, with a Debt / Equity ratio of 0.18.
| Current Ratio | 10.72 |
| Quick Ratio | 10.55 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -142.48 |
Financial Efficiency
Return on equity (ROE) is -42.39% and return on invested capital (ROIC) is -25.97%.
| Return on Equity (ROE) | -42.39% |
| Return on Assets (ROA) | -22.08% |
| Return on Invested Capital (ROIC) | -25.97% |
| Return on Capital Employed (ROCE) | -34.79% |
| Weighted Average Cost of Capital (WACC) | 7.26% |
| Revenue Per Employee | $30,526 |
| Profits Per Employee | -$1.15M |
| Employee Count | 152 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.31% in the last 52 weeks. The beta is 0.78, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -6.31% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 29.03 |
| Average Volume (20 Days) | 9,327,407 |
Short Selling Information
The latest short interest is 53.41 million, so 15.46% of the outstanding shares have been sold short.
| Short Interest | 53.41M |
| Short Previous Month | 55.61M |
| Short % of Shares Out | 15.46% |
| Short % of Float | 18.95% |
| Short Ratio (days to cover) | 9.06 |
Income Statement
In the last 12 months, ALLO had revenue of $4.64 million and -$174.46 million in losses. Loss per share was -$0.62.
| Revenue | 4.64M |
| Gross Profit | -86.72M |
| Operating Income | -190.21M |
| Pretax Income | -174.46M |
| Net Income | -174.46M |
| EBITDA | -179.22M |
| EBIT | -190.21M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $332.60 million in cash and $79.01 million in debt, with a net cash position of $253.60 million or $0.73 per share.
| Cash & Cash Equivalents | 332.60M |
| Total Debt | 79.01M |
| Net Cash | 253.60M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 436.18M |
| Book Value Per Share | 1.26 |
| Working Capital | 308.27M |
Cash Flow
In the last 12 months, operating cash flow was -$102.20 million and capital expenditures -$402,000, giving a free cash flow of -$102.60 million.
| Operating Cash Flow | -102.20M |
| Capital Expenditures | -402,000 |
| Depreciation & Amortization | 10.99M |
| Net Borrowing | n/a |
| Free Cash Flow | -102.60M |
| FCF Per Share | -$0.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,099.33% |
| Pretax Margin | -3,759.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -31.69% |
| Shareholder Yield | -31.69% |
| Earnings Yield | -59.28% |
| FCF Yield | -28.55% |
Analyst Forecast
The average price target for ALLO is $9.00, which is 765.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 765.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |